OPEN-LABEL RANDOMIZED CONTROLLED TRIAL OF VONOPRAZAN AND ESOMEPRAZOLE IN FIRST-LINE TRIPLE THERAPY AGAINST HELICOBACTER PYLORI INFECTION

被引：2
|
作者：
Tamaki, Hiroyuki
Morita, Masahiro
Noda, Teruyo
Izuta, Masako
Kubo, Atsushi
Ogawa, Chikara
Matsunaka, Toshihiro
Shibatoge, Mitsushige
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31120-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1190
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [1] An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for Helicobacter pylori infection
    Tamaki, Hiroyuki
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 36 - 36
  • [2] AN OPEN-LABEL, MULTI-CENTER, RANDOMIZED, SUPERIORITY TRIAL OF VONOPRAZAN VERSUS ESOMEPRAZOLE AS PART OF FIRST-LINE TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTION
    Tamaki, Hiroyuki
    Noda, Teruyo
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S89 - S89
  • [3] Comparative study of lansoprazole and esomeprazole in first-line triple therapy for Helicobacter pylori infection-an open label randomized controlled trial
    Noda, Teruyo
    Tamaki, Hiroyuki
    Arasawa, Shuichi
    Izuta, Masako
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatouge, Mitsushige
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 123 - 123
  • [4] A MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL OF VONOPRAZAN VERSUS PPI BASED 7-DAY TRIPLE THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION
    Sue, Soichiro
    Kuwashima, Hirohumi
    Arima, Isao
    Ogushi, Marina
    Nakao, Satoshi
    Naito, Makoto
    Komatu, Kazuto
    Yamada, Hiroaki
    Kaneko, Hiroaki
    Tamura, Toshihide
    Sasaki, Tomohiko
    Kondo, Masaaki
    Shibata, Wataru
    Maeda, Shin
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S250 - S250
  • [5] Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial
    Lu, Lifen
    Wang, Yujing
    Ye, Jun
    Han, Yuehua
    Lou, Guochun
    Li, Yan
    Yan, Huihui
    Du, Qin
    [J]. HELICOBACTER, 2023, 28 (01)
  • [6] Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Chang, Chi-Yang
    Fang, Yu-Jen
    Lee, Ji-Yuh
    Hsu, Shih-Jer
    Luo, Jiing-Chyuan
    Chang, Wen-Hsiung
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Tseng, Ping-Huei
    Wang, Hsiu-Po
    Yang, Ueng-Cheng
    Shun, Chia-Tung
    Lin, Jaw-Town
    Lee, Yi-Chia
    Wu, Ming-Shiang
    [J]. LANCET, 2013, 381 (9862): : 205 - 213
  • [7] Berberine-, Allicin- or Clarithromycin-Based Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection: an Open-Label, Randomized Trial
    Zhang, Xiaomei
    Yang, Yunsheng
    Gang, Sun
    Yang, Chao
    Lu, Mingliang
    Zhi, Junli
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S398 - S398
  • [8] Seven-Day Vonoprazan-Based Triple Therapy as First-Line Helicobacter pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial
    Chiu, Yu-Tse
    Lee, Fu-Jen
    Kuo, Chen-Ya
    Chen, Yu-Tsung
    Lin, Yang-Chao
    Liang, Kai-Shun
    Wu, Chun-Ying
    Lin, Ro-Ting
    Lin, Jaw-Town
    Chang, Chi-Yang
    [J]. HELICOBACTER, 2024, 29 (04)
  • [9] Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
    Cheung, Ka Shing
    Lyu, Tao
    Deng, Zijie
    Han, Shaowei
    Ni, Li
    Wu, Juan
    Tan, Jing Tong
    Qin, Jian
    Ng, Ho Yu
    Leung, Wai K.
    Seto, Wai-Kay
    [J]. HELICOBACTER, 2024, 29 (05)
  • [10] Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial
    Zhang, Yi
    Zhu, Yang-Jie
    Zhao, Zhe
    Zhao, Jing-Tao
    Wang, Ting-Yi
    Yang, Jing
    Chen, Dong-Feng
    Lan, Chun-Hui
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (05) : 563 - 568
12345